These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9124867)

  • 41. Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy.
    Asner SA; Giulieri S; Diezi M; Marchetti O; Sanglard D
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7715-22. PubMed ID: 26438490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis.
    Roberts JA; Udy AA; O'Donoghue S; Briscoe S; Paterson DL; Lipman J
    Int J Antimicrob Agents; 2009 Oct; 34(4):383-4. PubMed ID: 19540094
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
    O'Day DM; Ray WA; Robinson R; Head WS
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):331-5. PubMed ID: 6321389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
    Rabinovich S; Shaw BD; Bryant T; Donta ST
    J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179
    [No Abstract]   [Full Text] [Related]  

  • 45. Candida osteomyelitis as a complication of parenteral nutrition in an infant. Successful treatment with flucytosine.
    Berant M; Kristal C; Wagner Y
    Helv Paediatr Acta; 1979 May; 34(2):155-60. PubMed ID: 110730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraocular penetration of systemically administered antifungal agents.
    O'Day DM; Head WS; Robinson RD; Stern WH; Freeman JM
    Curr Eye Res; 1985 Feb; 4(2):131-4. PubMed ID: 3987346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
    Spreghini E; Orlando F; Tavanti A; Senesi S; Giannini D; Manso E; Barchiesi F
    J Antimicrob Chemother; 2012 Sep; 67(9):2195-202. PubMed ID: 22635526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
    Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
    Infection; 1996; 24(6):426-32. PubMed ID: 9007589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multifocal osteoarthritis due to Candida albicans in a neonate: serum level monitoring of liposomal amphotericin B and literature review.
    Evdoridou J; Roilides E; Bibashi E; Kremenopoulos G
    Infection; 1997; 25(2):112-6. PubMed ID: 9108188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections.
    White DJ; Habib AR; Vanthuyne A; Langford S; Symonds M
    Sex Transm Infect; 2001 Jun; 77(3):212-3. PubMed ID: 11402233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Candida albicans arthritis treated with flucytosine.
    Lindström FD; Lindholm T
    Ann Intern Med; 1973 Jul; 79(1):131. PubMed ID: 4578636
    [No Abstract]   [Full Text] [Related]  

  • 54. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tinospora cordifolia Aqueous Extract Alleviates Cyclophosphamide- Induced Immune Suppression, Toxicity and Systemic Candidiasis in Immunosuppressed Mice: In vivo Study in Comparison to Antifungal Drug Fluconazole.
    Alrumaihi F; Allemailem KS; Almatroudi A; Alsahli MA; Khan A; Khan MA
    Curr Pharm Biotechnol; 2019; 20(12):1055-1063. PubMed ID: 31333126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquired Flucytosine Resistance during Combination Therapy with Caspofungin and Flucytosine for Candida glabrata Cystitis.
    Charlier C; El Sissy C; Bachelier-Bassi S; Scemla A; Quesne G; Sitterlé E; Legendre C; Lortholary O; Bougnoux ME
    Antimicrob Agents Chemother; 2016 Jan; 60(1):662-5. PubMed ID: 26525799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of a murine model of hepatic candidiasis.
    Cole GT; Lynn KT; Seshan KR
    J Clin Microbiol; 1990 Aug; 28(8):1828-41. PubMed ID: 2394804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pradimicin therapy of disseminated Candida tropicalis infection in the mouse.
    Restrepo MI; Najvar LK; Fothergill AW; Graybill JR
    Med Mycol; 1998 Jun; 36(3):181-4. PubMed ID: 9776832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis.
    Farzanegan A; Roudbary M; Falahati M; Khoobi M; Gholibegloo E; Farahyar S; Karimi P; Khanmohammadi M
    J Mycol Med; 2018 Dec; 28(4):628-636. PubMed ID: 30126717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
    Nolte FS; Parkinson T; Falconer DJ; Dix S; Williams J; Gilmore C; Geller R; Wingard JR
    Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.